Pharmacovigilance in juvenile idiopathic arthritis patients (Pharmachild) treated with biologic agents and/or methotrexate. Consolidated baseline characteristics from Pharmachild and other national registries
针对接受生物制剂和/或甲氨蝶呤治疗的幼年特发性关节炎患者的药物警戒（Pharmachild）：来自 Pharmachild 和其他国家注册研究的综合基线特征
期刊:Rheumatology International
影响因子:2.9
doi:10.1007/s00296-013-2811-3
Bello, Kayode J; Fang, Hong; Fazeli, Parastoo; Bolad, Waleed; Corretti, Mary; Magder, Laurence S; Petri, Michelle; Consolaro, Alessandro; Dolezalova, Pavla; Panaviene, Violeta; Christensen, Anne Estmann; Merino, Rosa; Constantin, Tamas; Martini, Alberto; Ravelli, Angelo; Swart, Joost; Consolaro, Alessandro; Horneff, Gerd; Hyrich, Kimme L; Bovis, Francesca; Melo-Gomes, Jose; Alexeeva, Ekaterina; Lanni, Stefano; Ganser, Gerd; Panaviene, Violeta; Anton, Jordi; Foeldvari, Ivan; Stanevicha, Valda; Nielsen, Susan; Trauzeddel, Ralf; Ailioaie, Constantin; Quartier, Pierre; Hospach, Toni; Susic, Gordana; Trachana, Maria; Weller-Heinemann, Frank; Martini, Alberto; Wulffraat, Nico; Ruperto, Nicolino
